Combined Amylin/GLP-1 pharmacotherapy to promote and sustain long-lasting weight loss

A growing appreciation of the overlapping neuroendocrine mechanisms controlling energy balance has highlighted combination therapies as a promising strategy to enhance sustained weight loss. Here, we investigated whether amylin- and glucagon-like-peptide-1 (GLP-1)-based combination therapies produce...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Sci Rep
Glavni autori: Liberini, Claudia G., Koch-Laskowski, Kieran, Shaulson, Evan, McGrath, Lauren E., Lipsky, Rachele K., Lhamo, Rinzin, Ghidewon, Misgana, Ling, Tyler, Stein, Lauren M., Hayes, Matthew R.
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group UK 2019
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6560126/
https://ncbi.nlm.nih.gov/pubmed/31186439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-44591-8
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items